NH THERAGUIX SAS

NH TherAguix SAS Stock

Stocks

ALNHT

FR0013105954

Market Closed - Euronext Paris 11:34:17 22/10/21 am AEDT			5-day change	1st Jan Change
0.0100 ^EUR	-.--%		-.--%	-

03/09/24	NH TherAguix Announces Continuation of Phase II NANOBRAINMETS Trial in Treatment of Brain Metastases After Completion of Futility Analysis	CI
30/05/24	NH TherAguix Appoints Vincent Carrère as CEO	CI

Latest news: NH TherAguix SAS

03/09/24	NH TherAguix Announces Continuation of Phase II NANOBRAINMETS Trial in Treatment of Brain Metastases After Completion of Futility Analysis	CI
30/05/24	NH TherAguix Appoints Vincent Carrère as CEO	CI
30/05/24	NH TherAguix Announces AGuIX Receives Fast Track Designation from U.S. Food and Drug Administration	CI
28/10/21	NH TherAguix SAS and Carbogen AMCIS AG Announce the Release of New Batch of AGuIX Drug Product for Clinical Trials	CI

Press Releases: NH TherAguix SAS

18/06/24	NH TherAguix SAS : Nature’s Scientific Reports publishes an article describing the quantification of novel radio-enhancer AGuIX® developed in brain metastases	PU
19/12/23	NH TherAguix SAS : announces the publication of promising preclinical results of AGuIX® in combination with targeted radioligand therapies (TRT)	PU
12/09/23	NH TherAguix SAS : appoints Vincent Carrère as Chief Executive Officer	PU
21/07/23	NH TherAguix SAS : announces communications to be presented at the AAPM meeting by Harvard Medical Schools collaborators	PU
13/01/23	NH TherAguix SAS : announces the arrival of Aurélien Meyzaud as Head of Intellectual Property and Business Intelligence	PU

More press releases

News in other languages: NH TherAguix SAS

28/09/21

NhTherAguix: NH TherAguix annonce le lancement de son introduction en bourse sur le marché Euronext Growth à Paris

Managers and Directors: NH TherAguix SAS

Manager	Title	Age	Since
Vincent Carrère CEO	Chief Executive Officer	-	01/09/2023
Caroline Cayre DFI	Director of Finance/CFO	-	01/08/2019
Markus Loeffler CTO	Chief Tech/Sci/R&D Officer	-	01/01/2020

Director	Title	Age	Since
Olivier Tillement BRD	Director/Board Member	-	22/02/2019
Hervé Eloi Dominique Brailly CHM	Chairman	64	22/02/2019
Philippe Archinard BRD	Director/Board Member	66	22/02/2019

Financials

	2019	2020
Net sales	972K 871K 803K 727K 1.36M 92.56M 1.38M 9.58M 3.82M 48.44M 3.65M 3.57M 153M	1.32M 1.19M 1.09M 990K 1.85M 126M 1.88M 13.05M 5.21M 65.98M 4.97M 4.86M 209M
Net income	-2.7M -2.42M -2.23M -2.02M -3.78M -257M -3.84M -26.65M -10.63M -135M -10.14M -9.93M -427M	-4.34M -3.89M -3.59M -3.25M -6.08M -414M -6.17M -42.84M -17.09M -217M -16.31M -15.96M -686M
Net Debt	-	-

* Estimated data More financial data

Company Profile

Employees

14

Sector

-

More about the company

Stock Market
Stocks
ALNHT Stock

The best tools reserved for subscribers to boost the performance of your investments!